Arrowhead Pharmaceuticals Inc (ARWR) Ownership

18.05 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Arrowhead Pharmaceuticals Inc (ARWR), owning a total of 15.8 million shares. Combined, the top 47 institutional holders of ARWR own 96.85% of the company with a total of 118.6 million shares.

In the latest ownership report on September 30th 2024, the top 47 institutional holders increased their combined ownership of ARWR by 1.3 million shares. 14 institutions bought 5,405,506 total additional shares and increased their ownership by an average of 9.51%. However 7 institutions sold 4,148,653 total shares and decreased their ownership by an average of 17.62%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Arrowhead Pharmaceuticals increased by a net total of 1,256,853 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc12.726%0.974%15,835,912152,7062024-09-30
Vanguard Group Inc9.828%0.122%12,229,05514,9542024-09-30
venBio Select Advisor LLC7.143%0.000%8,888,88802024-09-30
State Street Corp5.107%8.849%6,354,331516,5692024-09-30
Fidelity Management and Research Company4.876%-10.931%6,067,569-744,6642024-09-30
FMR Inc4.876%-10.931%6,067,569-744,6642024-09-30
Slate Path Capital LP3.926%18.024%4,885,000746,0002024-09-30
T. Rowe Price Investment Management,Inc.2.873%39.586%3,574,5731,013,7402024-09-30
Geode Capital Management, LLC2.382%0.891%2,964,11926,1712024-09-30
Siren, L.L.C.1.976%0.000%2,458,7782,458,7782024-09-30
UBS Asset Mgmt Americas Inc1.731%-5.934%2,154,250-135,9042024-09-30
JPMorgan Chase & Co1.727%-7.225%2,148,405-167,3002024-09-30
Morgan Stanley - Brokerage Accounts1.291%-55.771%1,605,766-2,024,7902024-09-30
Northern Trust Corp1.071%0.760%1,332,76510,0472024-09-30
Goldman Sachs Group Inc1.023%0.749%1,272,9019,4592024-09-30
Citadel Advisors Llc0.946%24.159%1,177,577229,1332024-09-30
Charles Schwab Investment Management Inc0.809%1.265%1,006,93512,5742024-09-30
Bank of New York Mellon Corp0.696%-20.153%866,399-218,6702024-09-30
Woodline Partners LP0.696%5.390%865,79444,2762024-09-30
Western Financial Corp/CA0.659%0.000%820,23902024-09-30
Aquilo Capital Management, LLC0.640%-12.401%795,813-112,6612024-09-30
Millennium Management LLC USD0.519%21.985%645,604116,3532024-09-30
Bank of America Corp0.465%10.447%578,76054,7462024-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc12.726%0.974%15,835,912152,7062024-09-30
Vanguard Group Inc9.828%0.122%12,229,05514,9542024-09-30
venBio Select Advisor LLC7.143%0.000%8,888,88802024-09-30
State Street Corporation5.278%-3.874%6,560,703-264,4082024-03-31
State Street Corp5.107%8.849%6,354,331516,5692024-09-30
Fidelity Management and Research Company4.876%-10.931%6,067,569-744,6642024-09-30
FMR Inc4.876%-10.931%6,067,569-744,6642024-09-30
Slate Path Capital LP3.926%18.024%4,885,000746,0002024-09-30
T. Rowe Price Investment Management,Inc.2.873%39.586%3,574,5731,013,7402024-09-30
Artal Group S A2.566%5.029%3,189,389152,7212024-06-30
Geode Capital Management, LLC2.382%0.891%2,964,11926,1712024-09-30
AllianceBernstein L.P.2.418%4.768%2,584,693117,6332022-12-31
Siren, L.L.C.1.976%0.000%2,458,7782,458,7782024-09-30
Amvescap Plc.1.862%-5.597%2,306,308-136,7302023-12-31
UBS Asset Mgmt Americas Inc1.731%-5.934%2,154,250-135,9042024-09-30
JPMorgan Chase & Co1.727%-7.225%2,148,405-167,3002024-09-30
Credit Suisse First Boston (CSFB)1.308%-6.808%1,626,513-118,8292024-03-31
Morgan Stanley - Brokerage Accounts1.291%-55.771%1,605,766-2,024,7902024-09-30
NORGES BANK1.274%19.925%1,585,320263,3932024-06-30
Northern Trust Corp1.071%0.760%1,332,76510,0472024-09-30
Capital Research & Mgmt Co - Division 31.031%55.246%1,277,560454,6312023-12-31
Goldman Sachs Group Inc1.023%0.749%1,272,9019,4592024-09-30
Pictet Asset Manangement SA0.987%10,418.100%1,225,9871,214,3312024-03-31
Citadel Advisors Llc0.946%24.159%1,177,577229,1332024-09-30
First Manhattan Company0.971%-0.097%1,105,587-1,0752022-09-30
First Manhattan Co. LLC0.887%0.000%1,099,15402023-09-30
Fiera Capital Corporation1.014%-1.008%1,083,655-11,0372022-12-31
Avidity Partners Management LP0.859%15.016%1,063,897138,8972023-09-30
Charles Schwab Investment Management Inc0.809%1.265%1,006,93512,5742024-09-30
Ameriprise Financial Inc0.803%7.398%997,29768,6972024-03-31
Millennium Management LLC0.904%68.408%969,394393,7702023-03-31
Rokos Capital Management LLP0.756%-23.526%939,984-289,1642024-06-30
Bank of New York Mellon Corp0.696%-20.153%866,399-218,6702024-09-30
Woodline Partners LP0.696%5.390%865,79444,2762024-09-30
Western Financial Corp0.757%0.000%820,32002022-09-30
WESTERN FINANCIAL CORPORATION0.757%0.000%820,32002022-09-30
Western Financial Corp/CA0.659%0.000%820,23902024-09-30
Aquilo Capital Management, LLC0.640%-12.401%795,813-112,6612024-09-30
Nomura Holdings Inc0.710%17.181%761,147111,5992023-03-31
Renaissance Technologies Corp0.708%71.293%755,400314,4002022-09-30
Nuveen Asset Management, LLC0.661%10.118%700,27664,3422022-06-30
Dimensional Fund Advisors, Inc.0.642%94.109%687,911333,5162023-09-30
Point72 Asset Management, L.P.0.625%68.390%666,600270,7322022-09-30
Millennium Management LLC USD0.519%21.985%645,604116,3532024-09-30
COMMODORE CAPITAL LP0.569%6.087%610,00035,0002023-06-30
Bank of America Corp0.465%10.447%578,76054,7462024-09-30
HHG PLC0.523%-0.584%565,908-3,3252022-12-31

Mutual Fund Ownership

iShares Core S&P Mid-Cap ETF is the biggest individual fund holder of Arrowhead Pharmaceuticals Inc (ARWR), owning a total of 4 million shares. Combined, the top 37 mutual fund holders of ARWR own 42.13% of the company with a total of 51.1 million shares.

In the latest ownership report on December 31st 2024, the top 37 fund holders increased their combined ownership of ARWR by 19 thousand shares. 1 funds bought 13,433 total additional shares and increased their ownership by an average of 0.33%. However 3 funds sold 32,315 total shares and decreased their ownership by an average of 0.6%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Arrowhead Pharmaceuticals decreased by a net total of -18,882 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Mid-Cap ETF3.254%0.333%4,048,98613,4332024-12-31
iShares Russell 2000 ETF2.574%-0.383%3,202,284-12,3002024-12-31
SPDR® S&P Biotech ETF1.241%-1.156%1,543,881-18,0512024-12-31
iShares Russell 2000 Growth ETF0.880%0.000%1,095,31802024-12-31
iShares Biotechnology ETF0.607%-0.260%754,739-1,9642024-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Mid-Cap ETF3.254%0.333%4,048,98613,4332024-12-31
Vanguard Total Stock Mkt Idx Inv2.940%-0.495%3,658,560-18,1912024-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr3.000%5.227%3,215,729159,7362023-03-31
iShares Russell 2000 ETF2.574%-0.383%3,202,284-12,3002024-12-31
Vanguard Small Cap Index2.392%0.588%2,976,07017,4002024-11-30
Vanguard Institutional Extnd Mkt Idx Tr1.519%0.521%1,889,9369,7922024-11-30
Invesco Global Opportunities A1.456%0.000%1,803,70002023-12-31
Invesco Global Multi Cap Growth1.456%-9.815%1,803,700-196,3002023-12-31
Vanguard Small Cap Growth Index Inv1.316%0.653%1,636,90410,6122024-11-30
SPDR® S&P Biotech ETF1.241%-1.156%1,543,881-18,0512024-12-31
Vanguard Extended Market Index Investor1.364%0.318%1,462,2494,6362023-08-31
Fidelity Growth Compy Commingled Pl S1.097%1.603%1,365,49121,5372024-11-30
American Funds SMALLCAP World A1.031%55.246%1,277,560454,6312023-12-31
Fidelity Small Cap Index0.978%0.398%1,217,2504,8292024-10-31
Fidelity Growth Compy Commingled Pl O0.976%11.790%1,212,766127,9002024-08-31
UBS (Lux) Digital Health Equity SB USD0.964%0.000%1,200,00002024-11-30
CS (Lux) Digital Health Equity SB USD0.966%0.000%1,200,00002024-05-31
T. Rowe Price US Small-Cap Core Equity0.892%36.922%1,109,494299,1842024-09-30
T. Rowe Price Small-Cap Stock0.890%-0.165%1,107,665-1,8292024-10-31
iShares Russell 2000 Growth ETF0.880%0.000%1,095,31802024-12-31
SPDR® S&P MIDCAP 400 ETF Trust0.810%3.086%1,007,95130,1742024-11-30
Fidelity® Small Cap Index0.910%3.113%977,82329,5242023-10-31
Fidelity Growth Company Fund0.783%1.273%974,41412,2452024-11-30
Fidelity Small Cap Growth0.698%0.000%869,07002024-09-30
Fidelity® Select Biotechnology0.796%-18.107%854,632-188,9652023-11-30
JPMorgan Small Cap Growth A0.649%0.000%807,09902024-09-30
AB Small Cap Growth A0.722%-1.728%781,480-13,7432023-02-28
iShares S&P Mid-Cap 400 Growth ETF0.620%0.000%770,85202024-11-30
iShares Biotechnology ETF0.607%-0.260%754,739-1,9642024-12-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.589%0.000%732,43502024-11-30
Fidelity Select Biotechnology0.574%0.000%713,17002024-05-31
T. Rowe Price Small-Cap Value0.563%5.808%700,17538,4362024-10-31
Fidelity Extended Market Index0.553%-0.084%687,960-5762024-11-30
Pictet-Biotech P USD0.531%-0.979%659,564-6,5222024-03-31
Fidelity VIP Mid Cap Initial0.530%0.000%657,54002024-03-31
Fidelity® Extended Market Index0.537%1.125%577,0656,4212023-11-30
State St S&P Midcap® Indx SL Cl II0.479%0.000%514,01502023-11-30

Discussions

Please log in or register to share your thoughts.

breakthisgrip

$ARWR This may be your last opportunity to buy on the cheap??

0 Like Report
millimaker

$ARWR looking ready to breakout soon.

0 Like Report
SayMyName

$ARWR hows short doing? Keep short pls
we need your money.

0 Like Report
jchonnee

$ARWR this is my only green stonk!

I really like this stonk.

0 Like Report